Yahoo Finance Two baby formula products recalled over contamination fears
Two baby formula products have been recalled from sale in the UK over concerns they could contain dangerous bacteria.
Consumer goods giant Reckitt Benckiser has recalled several batches of its Nutramigen LGG stage 1 and stage 2 Hypoallergenic Formula powders after warning of potential contamination by Cronobacter sakazakii.
The bacteria most commonly causes symptoms such as fever and diarrhoea but in severe cases could cause sepsis or meningitis, according to the Food Standards Agency.
This could lead to symptoms such as poor feeding, irritability, temperature changes, jaundice and abnormal breathing.
Nutramigen is designed for infants with a mild to moderate allergy to cow’s milk. The products are mainly prescribed but are also available to buy over the counter.
In a recall notice, Reckitt told customers not to use products from the relevant batches which have an expiry date of July 1 2025.
The company said: “At Reckitt, we are committed to the highest level of quality and safety, and the health and safety of infants is our highest priority.
“As a precaution we are recalling the batches of the Nutramigen LGG Stage 1 and stage 2 set out in this notice due to an isolated overseas sample of the product testing positive for Cronobacter sakazakii, whilst we continue to conduct a thorough investigation.”
It comes days after Reckitt, which also owns brands including Nurofen and Strepsils, issued a recall notice for the formula products in the US.
This is not the first time the Slough-based company has been forced to pull its baby formula products from shelves due to health concerns.
In February, two batches of ProSobee 12.9 oz. Simply Plant-Based Infant Formula were recalled due to possible cross-contamination with Cronobacter sakazakii.
It is the latest setback for Reckitt, which has seen its share price languish for the last two years as the cost-of-living crisis forced many consumers to trade down to cheaper products.
Analysts at Citi last month cut their forecasts for the consumer goods group as sales growth remains subdued.
